NASDAQNYSEIBEX35LSEDAXCRYPTO
Buscar
IBEX:ROVI
Laboratorios Farmaceuticos Rovi S.A.
83,10 € Last price
+0,90 € VARIATION
+1,09% % VARIATION
UNKNOWN
The price of this share is at 83,10€, Laboratorios Farmaceuticos Rovi S.A., with address at desconocido, is a publicly traded company and its visible heads at the moment are desconocidos. Focused on desconocido was created long ago in desconocido.

The closing price of the stock yesterday was desconocido€.

The current range on the same day is from 81,35€ - 83,30€, with a percentage difference of 82,33€ quite wide that helps to be able to do day trading.

Their latest annual data shows an income of desconocido.

The opening price that appears as last recorded is desconocido.

If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00€ and 0,00€.

EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].

Updated graph

1D
1M
2M
3M
6M
1Y
Execution Report
Rovi
Daily 0.79%
Weekly -2.53%
Monthly 2.47%
Yearly 37.62%
1 year 100.90%
3 years 71.53%
Historical facts
ROVI - Rovi
Date Latest Minimum Maximum % Var. Volume
Similar stocks ROVI
Almirall
9,81 $
ALM
+0,01 $
+0,05 %
Detailed information of Almirall (ALM), stock of IBEX. All the technical analysis, execution, and the historical data of the last months, years and days. View Stock

This site uses third-party cookies to obtain statistical data on the navigation of our users, for segmented and personalized advertising and to improve the content offered by the site. If you accept or continue browsing, we consider that you agree to its use. Más información